Depakote
Abbott Laboratories
Uses and Important Safety Information  |   Prescribing Information
Smaller Text Text Size Larger Text   |   Print This Page  |   Bookmark

"In order to SUCCEED, we must first BELIEVE that we can."

Michael Korda
New York Times Bestselling Author

Already a member?

Sign up now for a free treatment support program.

Welcome to MyPartnersInCare.com!

Sign up here for the Partners in Care a free, online, treatment support program offering valuable information, expert tips, and tools to help you better manage epilepsy and stay on top of treatment.

Partners in Care is designed for people with epilepsy taking Depakote® (divalproex sodium delayed-release tablets) and Depakote® ER (divalproex sodium extended-release tablets), their loved ones, and their caregivers.

Sign up today! Complete the registration form below.

To get you started, we'll send you a free pill box to help you stay on top of your medications.

Please complete the fields below, and click "Register" when you're finished.

Free pill box*

Personal Information
* Denotes a Required Field
                                        
* First Name: 
* Last Name: 
* Address 1: 
Address 2: 
* City: 
* State:
* Zip Code:
* E-mail:
* E-mail (re-enter):
back to top 
Additional Information
* Denotes a Required Field
* 1. Are you a:




* 2. What age group does the patient (you or your loved one) fall into?





* 3. What is the patient's gender?


* 4. What Depakote formulation is the patient currently taking?



* 5. When was the patient diagnosed with epilepsy?
   -

* 6. When did the patient begin treatment with Depakote/DepakoteER?
   -

7. What, if anything, would prevent the patient from continuing treatment?
    (Check all that apply)





 

Yes, I would like to receive information about Depakote ER from MyPartnersInCare.com and Abbott Laboratories. I consent to this site's collection, use and disclosure of my information for this purpose. By submitting this registration, I agree that I am 14 years of age or older.

I give permission for my information to be used by Abbott and its contracted third parties to send me information about related products, services, offers, and for marketing purposes. Abbott will not sell or transfer my contact information to any third parties for their marketing use. I may be removed from Abbott's mailing list or request a copy of this information by contacting 800-580-6175. More information is available in this website's privacy policy.

* No purchase necessary for pill box. Allow 4-6 weeks for delivery. Subject to withdrawal without notice. For U.S. addresses only. One per household. While supplies last. Program may be discontinued at any time.
back to top
 

Please visit DepakoteER.com to view the full prescribing information.

USES1,2

  • Depakote ER is indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, with or without psychotic features.

  • Depakote is indicated for the treatment of manic episodes associated with bipolar disorder.

  • Depakote and Depakote ER are indicated for the treatment of complex partial seizures, and simple and complex absence seizures in adults and children 10 years of age and older with epilepsy.

  • Depakote and Depakote ER are indicated for the prevention of migraine headaches in adults.
IMPORTANT SAFETY INFORMATION1,2

Your doctor has prescribed Depakote or Depakote ER as part of your treatment plan. However, as with any medication, serious side effects can occur during treatment. It is very important that you know about these serious side effects and talk about them with your doctor.

The following serious side effects can occur with Depakote and Depakote ER:

Some people have experienced serious liver problems while taking valproic acid*. Your doctor should check your liver function before you start this medication and at frequent intervals thereafter. You will also be monitored for symptoms that lead to liver toxicity. Before taking this medication, tell your doctor if you have liver disease. Depakote or Depakote ER should not be taken if you have liver disease. Notify your doctor immediately if you develop malaise (illness), weakness, tiredness, facial swelling, and loss of appetite or vomiting.

Before taking valproate*, women who could become pregnant should talk with their doctor, as valproic acid has been associated with birth defects in children of women who have taken it while pregnant. If you become pregnant while taking this medication, contact your doctor immediately. Your doctor should advise you of the risk and alternative treatment options. Be sure to read the Patient Information Leaflet, which appears as the last section of the full Prescribing Information.

Some people taking valproate have experienced a serious, life-threatening problem called pancreatitis, which means that the pancreas has become inflamed. Call your doctor immediately if you experience stomach pain, nausea, vomiting, and/or loss of appetite, as these can be symptoms of pancreatitis.

Elevated ammonia levels and hypothermia, an unintentional drop in body temperature, have been reported in some patients receiving valproate. Contact your doctor immediately if you experience abnormal drowsiness and vomiting or changes in mental status.

A fever associated with other symptoms such as rash or enlargement of the lymph nodes should be reported to your physician immediately.


Some people taking Depakote and Depakote ER may experience low blood platelet counts. Your doctor should order blood tests to check your platelets while you are taking this medication, as well as prior to surgery.

You may experience drowsiness when you start this medication. You should not drive or operate dangerous machinery until you know how this medication will affect you.

You should not take this medication if you are allergic to it, or if you have a condition called urea cycle disorder, which may cause too much ammonia to build up in your body. Let your doctor know if you have been diagnosed with these conditions.


MANIA PIVOTAL TRIALS

The most common adverse (side) effects reported in clinical trials for mania with Depakote were nausea, vomiting, drowsiness, and dizziness.


MANIC OR MIXED EPISODES WITH OR WITHOUT
PSYCHOTIC FEATURES PIVOTAL TRIALS

The most common side effects reported in clinical trials for mania with Depakote ER were drowsiness, stomach upset following meals, nausea, vomiting, diarrhea, dizziness, and abdominal pain.


EPILEPSY CLINICAL TRIALS

The most common adverse (side) effects reported in epilepsy clinical trials with Depakote were tremor, nausea, abdominal pain, diarrhea, vomiting, low blood platelet count, weakness, drowsiness, dizziness, loss of appetite, and transient hair loss.


MIGRAINE PREVENTION

The most common adverse (side) effects reported in clinical trials for migraine prevention with Depakote were nausea, stomach upset following meals, weakness, diarrhea, abdominal pain, vomiting, dizziness, and drowsiness.

The most common adverse (side) effects reported in clinical trials with Depakote ER for migraine prevention were nausea, stomach upset following meals, diarrhea, vomiting, abdominal pain, and drowsiness.

This is not a complete list of reported side effects.


DOSING CONSIDERATIONS

Depakote and Depakote ER tablets should be swallowed whole and should not be crushed or chewed.

Keep Depakote ER and all other medication where children cannot reach them.

Please visit DepakoteER.com to view the full prescribing information.

* Divalproex sodium is a compound that contains sodium valproate and valproic acid.

References: 1. Depakote ER package insert. Abbott Laboratories: Abbott Park, IL. 2. Depakote package insert. Abbott Laboratories: Abbott Park, IL.



Uses and Important Safety Information | Prescribing Information
Terms of Use | Privacy Policy | Contact Us
Copyright ©2008 Abbott Laboratories, Abbott Park, Illinois, U.S.A.